SPDR S&P Biotech ETF Newsroom

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

Benzinga14:12 ET

Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report

Seeking Alpha11:35 ET

Peering Into Biogen's Recent Short Interest

Benzinga11:00 ET

Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report

Seeking AlphaJan 9 08:56 ET

S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today

Kevin TraversJan 8 16:12 ET

Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators

BenzingaJan 8 14:32 ET

Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development

BenzingaJan 8 14:09 ET

Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus

BenzingaJan 8 14:07 ET

Assessing AbbVie: Insights From 17 Financial Analysts

BenzingaJan 8 14:00 ET

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

BenzingaJan 8 12:54 ET

8 Health Care Stocks Whale Activity In Today's Session

BenzingaJan 8 12:35 ET

Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock

Kevin TraversJan 8 11:06 ET

Moderna Analyst Ratings

BenzingaJan 8 10:03 ET · Ratings

Neurocrine Biosciences Analyst Ratings

BenzingaJan 8 10:00 ET · Ratings

United Therapeutics Analyst Ratings

BenzingaJan 8 09:59 ET · Ratings

Compugen Announced That The First Patient Was Dosed In A Phase 1 Clinical Trial With Com503, A Potential First-in-class Antibody Against Il-18 Binding Protein Licensed By Compugen To Gilead

BenzingaJan 8 07:04 ET

Biogen Analyst Ratings

BenzingaJan 8 06:43 ET · Ratings

AbbVie Analyst Ratings

BenzingaJan 8 06:39 ET · Ratings

Express News | Moderna and Novavax Surge Over 5% and 6% Respectively on CDC Report of Rising Respiratory Illness

Moomoo 24/7Jan 8 05:07 ET

Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

BenzingaJan 7 21:16 ET